TABLE OF CONTENTS
1 INTRODUCTION 10
1.1 OBJECTIVES OF THE STUDY 10
1.2 MARKET DEFINITION 10
1.3 OVERVIEW OF NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET 10
1.4 CURRENCY AND PRICING 11
1.5 LIMITATIONS 11
1.6 MARKETS COVERED 12
2 MARKET SEGMENTATION 13
2.1 MARKETS COVERED 13
2.2 GEOGRAPHIC SCOPE 14
2.3 YEARS CONSIDERED FOR THE STUDY 14
2.4 CURRENCY AND PRICING 14
2.5 RESEARCH METHODOLOGY 15
2.6 DBMR MARKET POSITION GRID 19
2.7 DBMR MARKET CHALLENGE MATRIX 20
2.8 DBMR MARKET TIMELINE 21
2.9 DBMR MULTIVARIATE MODEL 21
2.10 SECONDARY SOURCES 22
2.11 ASSUMPTIONS 22
3 EXECUTIVE SUMMARY 23
4 PREMIUM INSIGHTS 25
5 PRIMARY INSIGHTS 26
6 MARKET OVERVIEW 27
6.1 DRIVERS 29
6.1.1 REGULATIONS THAT ARE DRIVING THE BIOLOGICAL SAFETY CABINET MARKET 29
6.1.2 INCREASING INFECTIOUS DISEASES IN LABORATORY 29
6.1.3 INCREASING NUMBER OF R&D ACTIVITIES 30
6.2 RESTRAINT 30
6.2.1 HIGH COST 30
6.3 OPPORTUNITY 31
6.3.1 RAPID GROWTH IN THE NUMBER OF BIOLOGICS DRUG 31
6.4 CHALLENGE 31
6.4.1 ALTERNATIVES OF BIOLOGICAL SAFETY CABINETS 31
?
7 NORTH AMERICA BIOLOGICAL SAFTEY CABINET MARKET, BY TYPE 32
7.1 OVERVIEW 33
7.2 CLASS I 34
7.3 CLASS II 34
7.3.1 TYPE A2 34
7.3.2 TYPE B2 34
7.3.3 TYPE A1 35
7.3.4 TYPE B1 35
7.4 CLASS III 35
8 NORTH AMERICA BIOLOGICAL SAFTEY CABINET MARKET, BY FILTER TYPE 36
8.1 OVERVIEW 37
8.2 HIGH EFFICIENCY PARTICULATE AIR FILTER (HEPA) 38
8.3 ULTRA LOW PENETRATION AIR FILTER (ULPA) 38
9 NORTH AMERICA BIOLOGICAL SAFTEY CABINET MARKET, BY END USER 39
9.1 OVERVIEW 40
9.2 ACADEMIC & RESEARCH INSTITUTIONS 41
9.3 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 41
9.4 DIAGNOSTIC AND TESTING LABORATORIES 41
9.5 INDUSTRIAL 41
9.6 OTHERS 41
10 NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET BY COUNTRY 42
10.1 NORTH AMERICA 42
10.1.1 U.S. 47
10.1.2 CANADA 49
10.1.3 MEXICO 51
11 GLOBAL BIOLOGICAL SAFETY CABINET MARKET, COMPANY LANDSCAPE 53
11.1 COMPANY SHARE ANALYSIS; NORTH AMERICA 53
12 COMPANY PROFILES 54
12.1 THERMO FISHER SCIENTIFIC INC. 54
12.1.1 COMPANY SNAPSHOT 54
12.1.2 REVENUE ANALYSIS 54
12.1.3 PRODUCT PORTFOLIO 55
12.1.4 RECENT DEVELOPMENTS 56
12.2 NUAIRE 57
12.2.1 COMPANY SNAPSHOT 57
12.2.2 PRODUCT PORTFOLIO 57
12.2.3 RECENT DEVELOPMENT 58
12.3 ESCO MICRO PTE LTD 59
12.3.1 COMPANY SNAPSHOT 59
12.3.2 GEOGRAPHICAL PRESENCE 59
12.3.3 PRODUCT PORTFOLIO 60
12.3.4 RECENT DEVELOPMENT 62
12.4 BAKER 63
12.4.1 COMPANY SNAPSHOT 63
12.4.2 GEOGRAPHICAL PRESENCE 63
12.4.3 PRODUCT PORTFOLIO 64
12.4.4 RECENT DEVELOPMENT 64
12.5 KEWAUNEE SCIENTIFIC CORPORATION 65
12.5.1 COMPANY SNAPSHOT 65
12.5.2 REVENUE ANALYSIS 65
12.5.3 PRODUCT PORTFOLIO 66
12.5.4 RECENT DEVELOPMENT 66
12.6 AIRCLEAN SYSTEMS, INC. 67
12.6.1 COMPANY SNAPSHOT 67
12.6.2 GEOGRAPHICAL PRESENCE 67
12.6.3 PRODUCT PORTFOLIO 68
12.6.4 RECENT DEVELOPMENT 68
12.7 AIR SCIENCE LLC 69
12.7.1 COMPANY SNAPSHOT 69
12.7.2 GEOGRAPHICAL PRESENCE 69
12.7.3 PRODUCT PORTFOLIO 70
12.7.4 RECENT DEVELOPMENT 70
12.8 AZBIL TELSTAR, S.L. 71
12.8.1 COMPANY SNAPSHOT 71
12.8.2 PRODUCT PORTFOLIO 72
12.8.3 RECENT DEVELOPMENT 72
12.9 BIGNEAT LTD 73
12.9.1 COMPANY SNAPSHOT 73
12.9.2 GEOGRAPHICAL PRESENCE 73
12.9.3 PRODUCT PORTFOLIO 74
12.9.4 RECENT DEVELOPMENT 74
12.10 BIOQUELL PLC 75
12.10.1 COMPANY SNAPSHOT 75
12.10.2 REVENUE ANALYSIS 75
12.10.3 PRODUCT PORTFOLIO 76
12.10.4 RECENT DEVELOPMENT 76
12.11 FLOW SCIENCES, INC. 77
12.11.1 COMPANY SNAPSHOT 77
12.11.2 PRODUCT PORTFOLIO 77
12.11.3 RECENT DEVELOPMENT 78
12.12 GERMFREE 79
12.12.1 COMPANY SNAPSHOT 79
12.12.2 PRODUCT PORTFOLIO 79
12.12.3 RECENT DEVELOPMENT 80
12.13 LABCONCO 81
12.13.1 COMPANY SNAPSHOT 81
12.13.2 PRODUCT PORTFOLIO 81
12.13.3 RECENT DEVELOPMENT 82
12.14 TERRA UNIVERSAL INC. 83
12.14.1 COMPANY SNAPSHOT 83
12.14.2 PRODUCT PORTFOLIO 83
12.14.3 RECENT DEVELOPMENT 83
12.15 TOPAIR SYSTEMS 84
12.15.1 COMPANY SNAPSHOT 84
12.15.2 GEOGRAPHICAL PRESENCE 84
12.15.3 PRODUCT PORTFOLIO 85
12.15.4 RECENT DEVELOPMENT 85
13 QUESTIONNAIRE 86
14 RELATED REPORTS 88